Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SLNO Gross Margin

The Gross Margin of Soleno Therapeutics Inc (SLNO) is 40.98%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

SLNO Gross Margin - Historical Value
Date Value
2024-12-31 40.98%
2023-12-31 40.98%
SLNO Gross Margin - Peers Comparison